348
Views
4
CrossRef citations to date
0
Altmetric
Application Note

A three-state continuous time Markov chain model for HIV disease burden

, &
Pages 1671-1688 | Received 21 Aug 2017, Accepted 30 Nov 2018, Published online: 10 Dec 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Alexa C. Klimchak, Lauren E. Sedita, Katherine L. Gooch & Daniel C. Malone. (2023) Assessing the impact of single or short-term administration on a therapy’s cost-effectiveness: a hypothetical disease-agnostic model. Journal of Medical Economics 26:1, pages 594-602.
Read now
Xu Zhang, Sean Barnes, Bruce Golden & Paul Smith. (2021) A continuous-time Markov model for estimating readmission risk for hospital inpatients. Journal of Applied Statistics 48:1, pages 41-60.
Read now

Articles from other publishers (2)

Akhtar Hossain, Farahnaz Islam & Hrishikesh Chakraborty. (2022) Parametric Regression Model Based on Reversed Hazard Rate: An Application to left censored heavy tailed HIV Viral Load Data. Bulletin of the Malaysian Mathematical Sciences Society 45:S1, pages 567-598.
Crossref
Hrishikesh Chakraborty, Akhtar Hossain, Sanku Dey & Sujit K. Ghosh. (2022) Modeling Right-skewed Heavy-tail Right-censored Survival Data with Application to HIV Viral Load. Bulletin of the Malaysian Mathematical Sciences Society 45:S1, pages 365-393.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.